Morphological findings in fatal cases of hantavirus cardiopulmonary syndrome. Report of 7 autopsies;Hallazgos morfológicos en casos fatales de síndrome cardiopulmonar por hantavirus. Estudio de 7 autopsias

Revista Chilena de Infectologia

Volumn 27, Issue 5, 2010, Pages 398-405

  Pablo Guzman G ^a,b   Oscar Tapia, E ^a,b   Miguel Villaseca, H ^a,b   Juan Araya, O ^a,b   Lilia Antonio, P ^a,b   Bolivar Lee O ^a,b   Juan Roa, S ^a,b  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b Hospital Regional de Temuco   (Chile)

Author keywords

Autopsy; Hantavirus; Hantavirus cardiopulmonary syndrome; Severe atypical pneumonias

Indexed keywords

EID: 78649750823     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Meissner J, Rowe J, Borucki M, St Jeor S. Complete nucleotide sequence of a Chilean hantavirus. Virus Res 2002; 89: 131-43.
2. Kraus A, Priemer C, Heider H, Krüger D, Ulrich R. Inactivation of hantan virus-containing samples for subsequent investigations outside biosafety level 3 facilities. Intervirology 2005; 48: 255-61.
3. Sotomayor V, Olea A, Labraña M (eds.). Diagnóstico y manejo del síndrome cardiopulmonar por hantavirus. Chile-2007. Rev Chil Infect 2009; 1: 68-86.
4. Boletín Epidemiológico de Hantavirus. Situación al 24 de junio de 2010. Departamento de Epidemiología. Ministerio de salud. http://epi.minsal.cl/epi/html/bolets/reportes/ Hantavirus/Hantavirus.pdf (acccedido julio 2010)
5. Shi X, McCaughey C, Elliot M. Genetic characterisation of a hantavirus isolated from a laboratory-acquired infection. J Med Virol 2003; 71: 105-9.
6. Martínez P, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, et al. Person-to-person transmisión of Andes virus. Emerg Infect Dis 2005; 11: 1848-53.
7. Finkbeiner W, Ursell P, Davis R. Chapter 4: Basic Postmortem Examination. Autopsy Pathology. A Manual and Atlas. First edition. Philadelphia. Ed Churchill Livingstone 2004, 41-65.
8. Finkbeiner W, Ursell P, Davis R. Appendix B. Measures, weights and assesment of growth and development. Autopsy Pathology. A Manual and Atlas. First edition. Philadelphia. Ed Churchill Livingstone 2004: 41-65.
9. Bi F, Formenty P, Roth C. Hantavirus infection: a review and global update. J Infect Dev Ctries 2008; 2: 3-23.
10. Jonsson C, Hooper J, Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res 2008; 78: 162-9.
11. Nolte K, Feddersen R, Foucar K, Zaki S, Koster F, Madar D, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum-Pathol 1995; 26: 110-20.
12. Colby T, Zaki S, Feddersen R, Nolte K. Hantavirus pulmonary syndrome is distinguishable from acute interstitial pneumonia. Arch Pathol Lab Med 2000; 124: 1463-6.
13. Zaki S, Greer P, Coffield L, Goldsmith C, Nolte K, Foucar K, et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995 146: 552-79.
14. Steer A. Pathology of hemorragic fever: a comparision of the findings; 1951 and 1952. Am J Pathol 1955; 31: 201-21.
15. Tomashefski JF Jr. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000; 21: 435-66.
16. Gavrilovskaya I, Gorbunova E, Mackow N, Mackow E. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-direct permeability. J Virol 2008; 82: 5797-806.
17. Terajima M, Hayasaka D, Maeda K, Ennis F. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorragic fevers? Immunol Lett 2007; 113: 117-20.
18. Saggioro F, Rossi M, Duarte M, Martin C, Alves V, Moreli M. et al. Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis 2007; 195: 1541-9.
19. Borges A, Figueiredo L. Mechanisms of shock in hantavirus pulmonary syndrome. Curr Opin Infect Dis 2008; 21: 293-7.
20. Centers for Disease Control and Prevention & National Institutes of Health: Biosafety in Microbiological and Biomedical Laboratories (ed 5). Washington, U.S. Department of Health and Human Services, 2007.
21. Nolte K, Foucar K, Richmond J. Hantaviral biosafety issues in the autopsy room and laboratory: Concerns and recommendations. Hum Pathol 1996; 27: 1253-4.